Driehaus Capital Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Driehaus Capital Management LLC

  • $10.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$83.14 - $145.99 $4.23 Million - $7.42 Million
50,830 New
50,830 $7.41 Million
Q1 2022

May 16, 2022
SELL
$110.08 - $142.92 $19.8 Million - $25.7 Million
-180,126 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$99.73 - $148.48 $5.1 Million - $7.6 Million
51,180 Added 39.69%
180,126 $24.8 Million
Q3 2021

Nov 15, 2021
BUY
$98.85 - $138.91 $12.7 Million - $17.9 Million
128,946 New
128,946 $17.9 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email